Cellectar Biosciences Inc (CLRB)
3.04
-0.17
(-5.30%)
USD |
NASDAQ |
Apr 18, 16:00
3.06
+0.02
(+0.66%)
Pre-Market: 20:00
Cellectar Biosciences Cash from Operations (TTM): -32.38M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -32.38M |
| September 30, 2023 | -30.19M |
| June 30, 2023 | -29.14M |
| March 31, 2023 | -27.37M |
| December 31, 2022 | -25.22M |
| September 30, 2022 | -22.32M |
| June 30, 2022 | -21.74M |
| March 31, 2022 | -22.86M |
| December 31, 2021 | -22.57M |
| September 30, 2021 | -21.93M |
| June 30, 2021 | -19.00M |
| March 31, 2021 | -15.17M |
| December 31, 2020 | -13.93M |
| September 30, 2020 | -12.75M |
| June 30, 2020 | -12.79M |
| March 31, 2020 | -12.39M |
| December 31, 2019 | -11.69M |
| September 30, 2019 | -11.76M |
| June 30, 2019 | -11.18M |
| March 31, 2019 | -11.07M |
| December 31, 2018 | -11.44M |
| September 30, 2018 | -11.52M |
| June 30, 2018 | -11.10M |
| March 31, 2018 | -11.22M |
| December 31, 2017 | -11.02M |
| Date | Value |
|---|---|
| September 30, 2017 | -10.54M |
| June 30, 2017 | -10.21M |
| March 31, 2017 | -9.451M |
| December 31, 2016 | -8.282M |
| September 30, 2016 | -7.428M |
| June 30, 2016 | -7.379M |
| March 31, 2016 | -7.665M |
| December 31, 2015 | -8.213M |
| September 30, 2015 | -8.860M |
| June 30, 2015 | -8.792M |
| March 31, 2015 | -8.612M |
| December 31, 2014 | -8.840M |
| September 30, 2014 | -9.378M |
| June 30, 2014 | -9.834M |
| March 31, 2014 | -9.860M |
| December 31, 2013 | -9.155M |
| September 30, 2013 | -8.170M |
| June 30, 2013 | -7.307M |
| March 31, 2013 | -6.771M |
| December 31, 2012 | -6.585M |
| September 30, 2012 | -6.427M |
| June 30, 2012 | -6.267M |
| March 31, 2012 | -7.348M |
| December 31, 2011 | -5.970M |
| September 30, 2011 | -4.548M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-32.38M
Minimum
Dec 2023
-11.18M
Maximum
Jun 2019
-19.81M
Average
-21.74M
Median
Jun 2022
Cash from Operations (TTM) Benchmarks
| Perspective Therapeutics Inc | -36.91M |
| Eli Lilly and Co | 4.240B |
| Actinium Pharmaceuticals Inc | -47.34M |
| Bristol-Myers Squibb Co | 13.86B |
| Altimmune Inc | -75.81M |